New heart drug candidate tested for safety in 24 healthy adults
NCT ID NCT06615284
First seen Jan 04, 2026 · Last updated May 07, 2026 · Updated 17 times
Summary
This early-phase study tested the safety and how the body processes Atorvo+™ in 24 healthy adults aged 40 to 75. Participants received either the study drug or a placebo to check for side effects and measure drug levels in the blood. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Australia
Conditions
Explore the condition pages connected to this study.